U.S. costs saved through generics by therapy 2004-2013

This statistic displays the distribution of cost savings in the United States associated with using generic pharmaceuticals within the period 2004-2013, by therapeutic area. During this period, one percent of cost savings due to generic pharmaceuticals were within the blood disorder therapy area. Over the last decade, 1.46 trillion U.S. dollars were saved through the use of generic pharmaceuticals in the United States.